Dr Reddy’s Q2 Earnings; Net Profit Slips 15%
Dr Reddy’s Laboratories Ltd on Tuesday, 5 November, announced its quarterly earnings for the July-September quarter. The company reported a 15% year-on-year (YoY) decline in...
Tag : Dr Reddy’s Lab
Dr. Reddy’s Signs Licensing Deal with Gilead to Commercialise HIV Drug, Shares Trading Flat
Shares of Dr. Reddy’s Laboratories Ltd. are trading flat after touching a day’s high of Rs 6,795 on 3rd October. This follows the firm’s announcement...
Nestle India Joins Hands With Dr Reddy for Nutritional Health Solutions
Nestlé India and Dr Reddy’s Laboratories have established a joint venture to market their nutritional health products, vitamins, minerals, herbals, and supplements worldwide. The joint company, which will...
Nestle India Stocks Gained 3% on Q4FY24 Business and Financial Updates
Nestle India Limited’s stocks jumped 3% on April 25 after it published strong fourth quarter (Q4FY24) results, entered into a joint venture, and recommended a...
LIC Offloads 2% Stake in Sun Pharmaceutical
LIC (Life Insurance Corporation of India), on 14 September, had divested a 2.011% stake in Sun Pharmaceutical Industries Ltd, taking its stake in the company...
Dr. Reddy’s Introduces Generic Revlimid Capsules in the US
On Wednesday, Dr. Reddy’s Laboratories Ltd pronounced the unveiling of Lenalidomide Capsules. It is a Therapeutic Equivalent Generic Version of Revlimid (lenalidomide) Capsules sanctioned by...
Dr Reddy’s & Aurigene Signs MoU with DNDi on Neglected Tropical Diseases
Dr. Reddy’s Laboratories (DRL), its fully owned step-down subsidiary Aurigene Pharmaceutical Services, not-for-profit R&D organisation Drugs for Neglected Diseases initiative and DNDi India Foundation have...
Dr Reddy’s Signs Agreement with Olema Pharmaceuticals
Dr Reddy’s lab said its subsidiary had signed an agreement with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of...
Torrent Pharma Acquires Four Brands from Dr Reddy’s Lab
Ahmedabad-based Torrent Pharmaceuticals announced on May 27 that it had agreed with Dr Reddy’s lab to acquire four of its brands – “Styptovit-E”, “Finast”, “Finast-T”,...
Dr. Reddy Outlook for the Week (July 27,2020 – July 31, 2020)
EquityPandit’s Outlook for Dr. Reddy for the week (July 27,2020 – July 31, 2020) DR. REDDY: BSE: 500180| NSE: DRREDDY| ISIN: INE040A01026| SECTOR: PHARMA Stock closed...